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Relationship between fasting plasma glucose levels
and maternal food group and macronutrient intakes
in pregnancy
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and Michael J. TURNER2
1

School of Biological Sciences, Dublin Institute of Technology, Dublin 8, Republic of Ireland, and 2UCD Centre for
Human Reproduction, Coombe Women and Infants University Hospital, Dublin 8, Republic of Ireland

Abstract
Aim: Increased maternal body mass index (BMI) has been consistently associated with elevated blood glucose levels
during pregnancy. Studies to date investigating the relationship between maternal blood glucose levels and dietary
intake have shown mixed results. We investigated the association between maternal fasting plasma glucose (FPG)
levels and food group and macronutrient intakes in the ﬁrst trimester of pregnancy, after adjustment for maternal
bodyweight.
Methods: Women were recruited after sonographic conﬁrmation of an ongoing singleton pregnancy in the ﬁrst trimester. Dietary information was collected using the validated Willett Food Frequency Questionnaire. Maternal height
and weight were measured and BMI calculated. Body composition was measured using advanced bioelectrical impedance analysis. FPG levels were obtained for women who were selectively screened with a 75 g oral glucose
tolerance test.
Results: No associations were observed between maternal FPG levels and food group or macronutrient intakes but
higher energy and starch intakes were found in obese subjects (P = 0.009 and P = 0.03 respectively). On univariate
analysis, higher FPG levels were associated positively with higher maternal bodyweight, BMI, body fat, fat free mass
and visceral fat (all P < 0.001). However, on multivariate regression analysis, higher FPG levels remained associated
only with maternal BMI > 29.9 kg/m2 (OR 7.4, P = 0.01).
Conclusions: Our ﬁndings indicate that maternal BMI is the key determinant of maternal glycaemia. Interventions
which focus on overall energy restriction and especially the limitation of dietary starch to optimise prepregnancy
maternal bodyweight are likely to be useful in improving glycaemic control in higher risk pregnancies.

Key words: fasting plasma glucose, food group, gestational diabetes, obesity, pregnancy.

Introduction
Gestational diabetes mellitus (GDM) is associated with
adverse outcomes not only for the woman, but also for her
offspring.1–3 GDM has been associated with increased caesarean section rates and pre-eclampsia, while women who
develop GDM are also at increased risk of developing type
2 diabetes mellitus (T2DM) later in life.4,5 Offspring of
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mothers with GDM are at risk of macrosomia, as well as
obesity and T2DM later in life.4,5 In women with GDM,
higher levels of blood glucose pass through the placenta.
This results in foetal hyperinsulinaemia and hyperglycaemia
leading to an increase in foetal fat and protein stores, and
subsequently macrosomia.6
While the deﬁnition of GDM as glucose intolerance with
onset or ﬁrst recognition during pregnancy is largely
accepted, the exact level of glucose intolerance which
deﬁnes GDM remains contentious.1–4,7,8 The Hyperglycaemia and Adverse Pregnancy Outcome study found a linear
association between maternal plasma glucose (PG) levels
and adverse perinatal outcomes across the whole distribution of PG levels in pregnancy.9 Thus, there is no clear PG
threshold above which women and their offspring are at
high clinical risk and below which they are at low risk. Criteria for the diagnosis of GDM have been developed, however, in an attempt to identify thresholds which best predict
adverse maternal and neonatal outcomes. Unfortunately,
441
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clear evidence demonstrating improved clinical outcomes
through the use of one criterion over another has remained
elusive. This has led to the use of several different criteria
for the diagnosis of GDM which are arbitrary and often
based on expert opinion.7 Diagnosis of GDM can be further
complicated by poorly controlled pre-analytical handling of
the fasting glucose sample.8
Diet and physical activity level (PAL) have been proposed as modiﬁable risk factors for the development of
GDM.10–16 However, diet and lifestyle interventions to
enhance blood glucose control in pregnancy have yielded
inconsistent results.17 Conversely, it is established that the
risk of developing GDM is increased in women with higher
prepregnancy body mass index (BMI), and that this risk
increases progressively across the BMI categories of overweight and obesity.18–20 Total body fat mass has also been
linked to insulin resistance.21–23 However, there is a lack of
studies examining the association between maternal fat
mass and glycaemic control during pregnancy.
Effective interventions to prevent and treat GDM are
important to reduce the short- and long-term adverse
health consequences for women and their offspring. The
aim of this study was to investigate the association between
maternal FPG levels and energy intake (EI), PAL, food
group intake and macronutrient intake in the ﬁrst trimester
of pregnancy after adjustment for bodyweight and other
potential confounders.

Methods
The Coombe Women and Infants University Hospital is
one of the largest maternity hospitals in the European
Union (EU) and cares for women from all socioeconomic
groups and from across the urban–rural divide. Women
were recruited at their convenience between February and
August 2013 as part of a longitudinal study investigating
maternal weight trajectories.24,25 The women’s clinical and
socio-demographic details were computerised routinely at
the ﬁrst antenatal visit. The main inclusion criteria were
women booking for antenatal care after an ultrasound conﬁrmation of a singleton ongoing pregnancy in the ﬁrst trimester. Exclusion criteria included multiple pregnancies,
women with pre-existing diabetes or women who subsequently delivered in another hospital.
To collect habitual food and nutrient intakes, women
were asked to complete the previously validated semiquantitative Willett Food Frequency Questionnaire
(WFFQ).26–28 Socioeconomic, health behavioural and
physical activity data were also collected using an online
questionnaire. Height was measured to the nearest centimetre using a Seca wall-mounted digital metre stick
with the woman standing in her bare feet. Weight was
measured digitally to the nearest 0.1 kg and BMI calculated.
Body composition was measured using an eight-lead multifrequency bioelectrical impedance analyser (BIA) (Tanita
MC 180, Tokyo, Japan).29,30
Of a total study population of 524 women, oral glucose
tolerance tests (OGTT) were performed between weeks
442

24 and 28 of gestation on a cohort 180 women identiﬁed
to have risk factors for GDM according to national screening guidelines.24,31 Written informed consent was obtained
from all study participants. The study was approved by the
Coombe Women and Infants University Hospital Research
Ethics Committee.
The FFQ used was a self-administered WFFQ adapted
from the European Prospective Investigation into Cancer
and Nutrition study and validated for use in Irish
adults.26,27,32 This WFFQ has also been recently validated
in an Irish obstetric population.28 Frequency of consumption of a ‘standard portion’ of each food or beverage item
consumed was divided into nine categories, ranging from
‘never or less than once per month’ to ‘six or more times
per day’. A ‘standard portion’ was quantiﬁed using the Food
Standards Agency’s Average Portion Sizes reference text.33
This dietary assessment protocol captured food and nutrient data reﬂective of the periconceptual period, as the
WFFQ focuses on consumption patterns over the previous
year. The WFFQ food intake data were entered into WISP
version 4.0 (Tinuviel Software, Llanfechell, Anglesey, UK)
to convert these reported food intakes into nutrient intakes.
The food composition tables used in WISP are derived from
McCance and Widdowson’s Food Composition Tables 5th
and 6th editions, and all supplemental volumes.34
The clinical and health behavioural data collected
included any applicable medical conditions and medications, as well as the woman’s smoking status. Questions
collecting socioeconomic data were derived from the EU
Survey on Income and Living Conditions 2012.35,36 Material indices of disadvantage included relative income poverty, as well as relative deprivation, while consistent
poverty status was also calculated using these two parameters. Relative income poverty status was calculated by
comparing equivalised household income against the 60%
median income threshold. Relative deprivation was assessed
by determining whether women had experienced the
enforced absence (due to ﬁnancial constraint) of two or
more basic necessities from a list of 11 over the previous
year. Consistent poverty was identiﬁed if a woman’s equivalised household income fell below the relative income poverty threshold, in addition to experiencing the enforced
absence of two or more of the 11 basic markers of deprivation over the preceding 12 months.
Self-assessed habitual PALs were also collected using a
self-administered, unsupervised questionnaire. Individual
PAL was estimated for each woman from 1.45 metabolic
equivalents (MET) (seated work with no option of moving
around and no strenuous leisure time activity), up to
2.20 MET (strenuous work or highly active leisure time
(e.g. competitive athletes in daily training).37
Women who under- and over-reported EI were excluded
from the ﬁnal food and nutrient intake datasets as previously described24 so as to enhance the integrity of our analyses.38 Data analyses were carried out using SPSS version
20.0 (IBM Corporation, Armonk, NY, USA). Descriptive
analyses were initially carried out to characterise the cohort
with respect to their age, parity, ethnicity, stage of gestation,
© 2016 Dietitians Association of Australia
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socioeconomic status, smoking status and PAL. One-way
ANOVA tests were used to compare mean values for continuous variables (age, gestational age, PAL) between the FPG
tertiles. Cross-tabulation with chi-square analyses were used
to test differences in categorical socioeconomic and health
behavioural variables across the FPG tertiles. Data for
weight, BMI, body fat mass, percentage body fat and fat free
mass were non-normally distributed. Kruskal–Wallis tests
were used to assess differences in these parameters between
the FPG tertiles. Kruskal–Wallis tests were also used to test
differences in median energy-adjusted food group and macronutrient intakes among women in each FPG tertile.
Binary logistic regression was used to assess factors associated with FPG levels >4.5 mmol/L. This regression model
incorporated variables such as antenatal obesity, family history of diabetes, early pregnancy weight, body fat %, fat free
mass, visceral fat level, age, parity, smoking status, Irish
nativity, glycaemic index of the diet and EI, sugar, carbohydrate, protein, fat and dietary ﬁbre intake. Mann–Whitney
U-test was used to assess differences in energy-adjusted
macronutrient intakes between obese and non-obese
women.

Results
OGTTs were undertaken by 180 women. GDM was diagnosed in 16 women (8.9%) according to the International
Association of Diabetes and Pregnancy Study Group recommendations.39 Mean FPG levels were 4.5 mmol/L (range
3.6–8.9 mmol/L). The social and demographic characteristics of this study population both overall, and according to
FPG level, are shown in Table 1. Women completed the
WFFQ at 12.6  2.8 weeks gestation. FPG levels increased
with increasing weight, BMI, body fat mass, percentage
body fat, fat free mass, and visceral fat (all P < 0.001)
(Table 2).
EI under-reporting was observed in 57 women (31.7%).
There were no EI over-reporters in the sample. EI underreporters in this sample had a higher weight (87.1  19.3
vs 73.9  15.2 kg (P = 0.001)), BMI (32.0  7.1 vs
26.9  5.5 kg/m2 (P = 0.001)), body fat % (37.1  7.4 vs
32.4  7.4% (P = 0.001)), and fat free mass (53.6  7.4 vs
49.0  5.9 kg (P = 0.001)) compared with plausible reporters of EI. No differences were seen in energy-adjusted food
group and macronutrient intakes across FPG tertiles
(Table 3).
On logistic regression only antenatal obesity
(BMI > 29.9 kg/m2; OR 7.4, P = 0.01) was associated with
a FPG level >4.5 mmol/L. Obese plausible reporters
(n = 35) had a higher EI (3254.9 vs 2281.5 kcal/day
(P = 0.009)), higher starch intake (28.2 vs 24.2% total
energy (TE) (P = 0.03)), higher maltose intake (0.65 vs
0.45% TE (P = 0.04)) and lower fructose intake (3.37 vs
3.88% TE (P = 0.03)) compared with non-obese women.
There was no difference in self-reported PAL between obese
and non-obese women (1.76  0.2 vs 1.75  0.2
(P = 0.598)).
© 2016 Dietitians Association of Australia

One- and two-hour post glucose load PG levels also
showed no association with maternal food and macronutrient intakes. The one-hour PG levels also increased as maternal weight, BMI and body composition increased.
Interestingly the two-hour PG levels were not as signiﬁcant
as the FPG or one-hour PG levels. Only BMI increased as
the two-hour PG levels increased (P = 0.03).

Discussion
This study found that maternal FPG levels at 24–28 weeks
gestation were not associated with food group and macronutrient intakes in the periconceptional period. Obesity in
early pregnancy was associated with higher FPG levels after
adjusting for important confounding variables. This suggests that weight management interventions should be targeted at women of child-bearing age in the prepregnancy
period, especially those who are obese. These weight management programmes should incorporate limitations on
overall dietary EI particularly that derived from starchy
foods, as high intakes of both were associated with maternal
obesity.
Our study has a number of strengths. Maternal weight
was measured, not self-reported. While the accurate assessment of bodyweight is critical, women, particularly those
who are obese, have been shown to commonly underestimate their weight when self-reporting, which may lead to
BMI mis-categorisation.40,41 BIA was used to measure
maternal weight and body composition.29,30 The maternal
weight was taken in the ﬁrst trimester, which has been
shown to be the optimal time for weight measurement in
pregnancy, as maternal weight and body composition only
begin to change after 18 weeks of gestation.30 The availability and use of the women’s body composition data is
another strength of this study. Given the lack of clear consensus around the exact level of glucose intolerance which
deﬁnes GDM, FPG levels were investigated in this
study.1–4,7,8
A possible limitation of this study is the difﬁculty associated with accurate assessment of dietary intake. The WFFQ
is a semi-quantitative FFQ and, therefore, does not facilitate
portion size estimation for individuals. Nonetheless, the
WFFQ has been validated as a dietary data collection
instrument in several Irish population studies, including a
recent study on pregnant women in Dublin.26–28,32 Another
potential weakness is that convenience recruitment may
introduce an unforeseen self-selection bias that was not
addressed in the multivariate analysis.
Women who under-reported their EI were excluded
from the ﬁnal food and nutrient intake datasets to enhance
the integrity of the population’s nutrient intake data.38
Under-reporting of EI is a phenomenon associated with dietary surveys and must be taken into account when interpreting the results of such surveys.24 Speciﬁcally, underreporting of EI is increased amongst women in higher BMI
categories and, therefore, needs to be considered when conducting research into GDM as increased BMI is associated
with the development of GDM. Disproportionate exclusion
443
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Table 1 Social and demographic characteristics of the study population analysed by fasting plasma glucose (FPG) levels in
early pregnancy (n = 180)
Lower FPG
(<4.3 mmol/
L) (n = 63)

Moderate FPG
(4.3–4.59 mmol/L) (n = 63)

Higher FPG
(≥4.6 mmol/
L) (n = 54)

P

30.6 (5.5)
41.1 (74)
22.6 (39)

30.4 (5.4)
38.1 (24)
19.1 (12)

30.2 (5.8)
39.7 (25)
20.6 (13)

31.2 (5.1)
46.3 (25)
25.9 (14)

0.58
0.64
0.55

32.2 (58)

33.3 (21)

31.8 (20)

31.5 (17)

0.97

11.1 (19)

11.5 (7)

8.2 (5)

14.0 (7)

0.62

31.7 (57)

25.4 (16)

34.9 (22)

35.2 (19)

0.41

12.6 (2.8)

12.5 (2.6)

12.6 (3.3)

12.6 (2.5)

0.96

74.4 (134)
11.1 (20)

69.8 (44)
11.1 (7)

74.6 (47)
11.1 (7)

79.6 (43)
11.1 (6)

0.48
1.00

1.75 (0.3)

1.70 (0.2)

1.70 (0.2)

1.80 (0.2)

0.06

Total
(n = 180)
(a)

Age (years)
Nulliparous % (n)
Relative income
poverty(b) % (n)
Relative deprivation
% (n)
Consistent poverty(b)
% (n)
Under-reporters %
(n)
Gestational age(a)
(weeks)
Irish-born % (n)
Current smoker %
(n)
Physical activity
level(a) (MET)

(a) Mean (SD).
(b) Data available on n = 172.
FPG, fasting plasma glucose; MET, metabolic equivalents.

Table 2 Univariate comparison of maternal anthropometric characteristics in early pregnancy analysed by fasting plasma glucose (FPG) levels (n = 180)

Weight (kg)
BMI (kg/m2)
% Body fat
(kg)
Fat mass (kg)
Fat free mass
(kg)
Visceral fat
level

Lower FPG
(<4.3 mmol/L) (n = 63)

Moderate FPG
(4.3–4.59 mmol/L) (n = 63)

Higher FPG
(≥4.6 mmol/L) (n = 54)

P

68.0 (15.0)
24.0 (5.0)
32.0 (9.0)

80.0 (22.0)
28.0 (10)
36.0 (11.0)

82.4 (23.3)
30.0 (8.3)
36.6 (9.0)

<0.001
<0.001
<0.001

21.0 (9.0)
46.0 (7.0)

29.0 (16.0)
51.0 (7.0)

30.5 (16.6)
53.0 (11.3)

<0.001
<0.001

4.0 (2.0)

5.8 (3.2)

6.0 (4.0)

<0.001

All values reported are median (interquartile range).

of obese women on the basis of dietary under-reporting
may therefore result in bias and erroneous conclusions
regarding the nutritional intakes and GDM risk proﬁle of
obese women, and this is an important limitation of the
current study. However, as the inclusion of under-reported
food group and nutrient intakes from these women would
have signiﬁcantly distorted the inferential associations
between population food and nutrient intake estimates and
GDM risk in the current cohort, their exclusion was necessary to preserve the veracity of ﬁndings from the remaining
dataset.24
It is established that the risk of developing GDM is
increased in women with higher prepregnancy BMI.18–20
Visceral fat and total body fat mass have been linked to
444

insulin resistance among general adult populations.21–23
However, there is a lack of studies investigating body fat
mass in pregnancy and how it affects the risk of developing
GDM. A cross-sectional study (n = 79) found that women
with GDM had higher body fat mass levels compared with
women with normal blood glucose levels.42 Univariate analysis in our study suggested that increased adiposity in early
pregnancy was associated with higher blood glucose levels.
However, after controlling for important confounding factors, only antenatal obesity as measured by BMI remained
associated with higher blood glucose levels.
Recent meta-analysis found no difference in the likelihood of developing GDM between women receiving diet
and exercise interventions, and those allocated to control
© 2016 Dietitians Association of Australia
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Table 3 Comparison of energy-adjusted food group macronutrient intakes in plausible reporters analysed by FPG tertiles (n = 123)
Food group (g/MJ
energy)
Breads
Breakfast cereals
Rice/pasta
Eggs
Potatoes
Fats/oils
Alcoholic drinks
Sugar groups
Fruit and vegetables
Milk/cream/cheese
Fish
Meat
Other drinks
Other foods
Energy (MJ/day)
Carbohydrate (% TE)
Sugars (% TE)
Starch (% TE)
NMES (% TE)
Fructose (% TE)
Sucrose (% TE)
Lactose (% TE)
Maltose (% TE)
Oligosaccharides (%
TE)
Fat (% TE)
Saturated fat (% TE)
Monounsaturated fat
(% TE)
Polyunsaturated fat (%
TE)
Dietary ﬁbre (per MJ
energy)
Protein (% TE)
Alcohol (g/day) (%
TE)

Low FPG
(<4.3 mmol/L) (n = 47)

Moderate FPG
(4.3–4.59 mmol/L) (n = 41)

High FPG
(≥4.6 mmol/L) (n = 35)

4.7 (7.1)
4.1 (8.2)
9.0 (8.8)
1.9 (1.7)
10.1 (7.1)
0.6 (1.0)
1.9 (9.4)
12.2 (11.0)
62.2 (36.2)
4.0 (5.5)
2.89 (4.6)
13.3 (6.6)
61.3 (64.4)
11.6 (9.9)
10.0 (5.8)
45.2 (8.3)
18.9 (6.2)
25.2 (10.2)
5.6 (2.5)
3.8 (2.4)
5.9 (3.4)
0.7 (0.7)
0.5 (0.7)
0.02 (0.1)

4.5 (5.2)
4.1 (5.5)
10.2 (9.8)
1.9 (1.5)
10.6 (6.4)
0.6 (0.7)
0.8 (6.2)
15.5 (13.4)
54.8 (46.3)
3.1 (3.6)
5.01 (6.93)
13.4 (6.4)
60.0 (59.5)
12.8 (12.5)
9.8 (4.7)
48.6 (8.9)
21.2 (7.6)
26.9 (9.2)
6.5 (4.9)
3.7 (2.9)
6.5 (2.8)
0.5 (0.5)
0.5 (0.6)
0.06 (0.1)

4.1 (7.1)
3.9 (4.9)
11.4 (9.9)
2.2 (1.9)
9.7 (7.8)
0.5 (0.5)
1.2 (4.3)
12.3 (11.5)
51.1 (35.9)
4.4 (4.7)
2.09 (3.97)
14.6 (9.3)
54.2 (67.1)
10.5 (13.7)
9.5 (3.3)
47.1 (9.4)
19.0 (7.1)
27.0 (7.8)
6.7 (4.1)
3.6 (2.0)
6.1 (3.4)
0.6 (0.5)
0.5 (0.6)
0.06 (0.2)

0.16
0.50
0.32
0.58
0.93
0.32
0.74
0.31
0.94
0.08
0.21
0.39
0.96
0.90
0.38
0.45
0.45
0.67
0.62
0.94
0.76
0.93
0.95
0.29

36.4 (7.8)
13.4 (4.2)
11.3 (2.3)

34.7 (6.2)
13.1 (2.8)
10.9 (2.7)

35.6 (10.3)
13.3 (4.2)
10.8 (3.1)

0.91
0.34
0.96

6.5 (2.8)

7.2 (3.1)

6.8 (2.4)

0.25

5.0 (1.8)

4.8 (2.9)

4.6 (2.4)

0.35

18.0 (5.8)
0.4 (2.0)

18.2 (4.2)
0.3 (1.2)

18.4 (4.7)
0.4 (1.6)

0.92
0.82

P

All values reported are median (interquartile range).
FPG, fasting plasma glucose; NMES, non-milk extrinsic sugars; TE, total energy.

groups.17,43 There was a trend towards a beneﬁcial effect
among women receiving primarily diet-based interventions,
however, with a potentially signiﬁcant reduction in GDM
risk observed when these interventions were limited to
obese and overweight women.43
Our study showed no association between energy
adjusted food group or macronutrient intakes and FPG
levels. However, while PAL levels were similar across all
BMI categories, overall dietary EI and starch consumption
were both higher among obese subjects. While causation
cannot be conﬁrmed, these ﬁndings suggest that excessive
dietary EI, especially that derived from starchy carbohydrate, may contribute to the development of obesity, the
main driver of GDM. This suggests that both excessive EI
© 2016 Dietitians Association of Australia

and high starchy food intake are important targets for dietary interventions in this area.
Previous studies investigating dietary intakes in early
pregnancy and the risk of developing GDM have yielded
inconsistent ﬁndings. In relation to macronutrients, some
studies have shown that the type and quantity of carbohydrate may inﬂuence maternal blood glucose concentrations.13 In non-obstetric populations, high fructose intake
has been linked with adverse metabolic effects.44 However,
there is a lack of studies investigating fructose consumption
and the development of GDM. While glycaemic index and
energy-adjusted carbohydrate or fructose intakes were not
associated with blood glucose levels in this study, high
starch intakes were associated with obesity, the main
445
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predictor of elevated maternal glucose. While further studies are needed to investigate the possible detrimental effects
of excessive fructose intake on maternal blood glucose
levels in pregnancy, research exploring the effect of high
starchy carbohydrate intake is also warranted.
Our ﬁndings indicate that weight management in the
prepregnancy period may have a more beneﬁcial effect on
FPG than altering diet in early pregnancy. Obesity was the
main driver of higher FPG levels. Obese women had higher
energy and starch intakes than non-obese women. Weight
loss prior to pregnancy in obese women, particularly
through a reduction in overall energy and starch intakes,
may be more effective in improving maternal glycaemic
control than attempts to adjust diet in early pregnancy.
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